Kayne Anderson Rudnick Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Kayne Anderson Rudnick Investment Management's RMD Position: Q2 2026 in Review
Kayne Anderson Rudnick Investment Management reduced its ResMed (RMD) stake by 10% in Q2 2026, selling an estimated $2.9K and leaving 126 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #676.
Kayne Anderson Rudnick Investment Management first reported a position in RMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $38.4K in Q2 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Kayne Anderson Rudnick Investment Management held 126 shares of ResMed worth $24.7K as of Q2 2026.
- Kayne Anderson Rudnick Investment Management sold 14 ResMed shares in Q2 2026, an estimated $2.9K.
- ResMed made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #676 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in ResMed in Q3 2022 and has held it in 16 quarters since.
- Kayne Anderson Rudnick Investment Management's ResMed position peaked at $38.4K in Q2 2025.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.